|
[1]
|
Siegel, R.L., Miller, K.D., Fuchs, H. and Jemal, A. (2021) Cancer Statistics, 2021. CA: A Cancer Journal for Clinicians, 71, 7-33. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Siegel, R.L., Miller, K.D. and Jemal, A. (2019) Cancer Statistics, 2019. CA: A Cancer Journal for Clinicians, 69, 7-34. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Jiang, X.Y., Tang, H.J. and Chen, T.H. (2018) Epidemiology of Gyneco-logic Cancers in China. Journal of Gynecologic Oncology, 29, e7. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Katz, M.S., Smith, L. and Simcock, R. (2018) Treatment Toxicity in Endometrial Cancer: Can We Identify and Manage It Bet-ter? The Lancet Oncology, 19, 602. [Google Scholar] [CrossRef]
|
|
[5]
|
Meyer, L.A., Bohlke, K. and Wright, A.A. (2016) Postoperative Radiation Therapy for Endometrial Cancer: American Society of Clinical Oncol-ogy Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Evidence-Based Guideline. Journal of Oncology Practice, 12, 182-185. [Google Scholar] [CrossRef]
|
|
[6]
|
Bestvina, C.M. and Fleming, G.F. (2016) Chemotherapy for Endometrial Cancer in Adjuvant and Advanced Disease Settings. The Oncolo-gist, 21, 1250-1259. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
de Haydu, C., Black, J.D., Schwab, C.L., English, D.P. and Santin, A.D. (2016) An Update on the Current Pharmacotherapy for Endometrial Cancer. Expert Opinion on Pharmacotherapy, 17, 489-499. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
王辉, 韩琛, 董新茜, 等. 子宫内膜癌组织中Ki-67、Bcl-2、p53蛋白表达变化及意义[J]. 山东医药, 2018, 58(21): 21-24.
|
|
[9]
|
Tao, Y. and Liang, B. (2020) PTEN Mutation: A Potential Prognostic Factor Associated with Immune Infiltration in Endometrial Carcinoma. Pathology—Research and Practice, 216, Article ID: 152943. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Hussain, S.P., Amstad, P., He, P., et al. (2004) P53-Induced Up-Regulation of MnSOD and GPx but Not Catalase Increases Oxidative Stress and Apoptosis. Cancer Research, 64, 2350-2356. [Google Scholar] [CrossRef]
|
|
[11]
|
Chio, I.I.C. and Tuveson, D.A. (2017) ROS in Cancer: The Burning Question. Trends in Molecular Medicine, 23, 411-429. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Zheng, W., Chen, Q., Wang, C., et al. (2020) Inhibition of Ca-thepsin D (CTSD) Enhances Radiosensitivity of Glioblastoma Cells by Attenuating Autophagy. Molecular Carcinogene-sis, 59, 651-660. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Ikeguchi, M., Sakatani, T., Ueta, T., et al. (2002) Correla-tion between Cathepsin D Expression and P53 Protein Nuclear Accumulation in Oesophageal Squamous Cell Carcinoma. Journal of Clinical Pathology, 55, 121-126. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Martínez, P.T., Navajas, P.L. and Lietha, D. (2020) FAK Structure and Regulation by Membrane Interactions and Force in Focal Adhesions. Biomolecules, 10, Article No. 179. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Alfieri, R., Giovannetti, E., Bonelli, M. and Cavazzoni, A. (2017) New Treatment Opportunities in Phosphatase and Tensin Homolog (PTEN)-Deficient Tumors: Focus on PTEN/Focal Adhe-sion Kinase Pathway. Frontiers in Oncology, 7, Article 170. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
何亚, 胡元晶. p53和MMR联合检测在子宫内膜癌预后判断中的作用[J]. 现代妇产科进展, 2019, 28(9): 651-656.
|
|
[17]
|
郭骏辉, 刘冬梅, 乔爱琪, 等. 错配修复蛋白表达与子宫内膜癌临床病理特征的关系[J]. 肿瘤研究与临床, 2017, 29(10): 649-652+666.
|
|
[18]
|
郭璐璐, 王翔宇, 付广明, 等. 不同错配修复蛋白检测组合对子宫内膜癌患者预后判断的价值及意义[J]. 精准医学杂志, 2022, 37(4): 365-369.
|
|
[19]
|
晋薇, 马亚琪, 王昀, 刘爱军. 错配修复基因MLH1、MSH2、MSH6及PMS2在子宫内膜癌中的表达及临床意义[J]. 诊断病理学杂志, 2018, 25(5): 335-339.
|
|
[20]
|
Cao. Y., Ye, Q., Zhuang, M., et al. (2017) Ginsenoside Rg3 Inhibits Angiogenesis in a Rat Model of Endometriosis through the VEGFR-2-Mediated PI3K/Akt/mTOR Signaling Pathway. PLOS ONE, 12, e0186520. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Álvarez-Garcia, V., Tawil, Y., Wise, H.M. and Leslie, N.R. (2019) Mechanisms of PTEN Loss in Cancer: It’s All about Diversity. Seminars in Cancer Biology, 59, 66-79. [Google Scholar] [CrossRef] [PubMed]
|